PREMIXED INSULIN REGIMEN TO BASAL-BOLUS INSULIN OUTCOMES IN TYPE 2 DIABETES SUBJECTS. (2023). International Research Journal of Pharmacy, 14(2), 40-48. https://doi.org/10.56802/enp5vh61